ASX - By Stock
|
BIT |
Re:
BIT Billionaires Club
|
|
Wonderous
|
95 |
34K |
9 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
95
|
34K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Wonderous
|
440 |
141K |
4 |
15/12/20 |
15/12/20 |
ASX - By Stock
|
440
|
141K
|
4
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Wonderous
|
368 |
119K |
8 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
368
|
119K
|
8
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Wonderous
|
368 |
119K |
8 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
368
|
119K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Wonderous
|
3.2K |
1.0M |
4 |
08/12/20 |
08/12/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Wonderous
|
440 |
141K |
5 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
440
|
141K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Wonderous
|
440 |
141K |
6 |
07/12/20 |
07/12/20 |
ASX - By Stock
|
440
|
141K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Wonderous
|
3.2K |
1.0M |
3 |
02/12/20 |
02/12/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Wonderous
|
3.2K |
1.0M |
7 |
01/12/20 |
01/12/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation to Annual General Meeting
|
|
Wonderous
|
29 |
6.8K |
3 |
28/11/20 |
28/11/20 |
ASX - By Stock
|
29
|
6.8K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
9 |
20/11/20 |
20/11/20 |
ASX - By Stock
|
221
|
58K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Annual Report and Notice of Annual General Meeting
|
|
Wonderous
|
117 |
29K |
6 |
19/11/20 |
19/11/20 |
ASX - By Stock
|
117
|
29K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Wonderous
|
13K |
6.3M |
5 |
18/11/20 |
18/11/20 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Wonderous
|
368 |
119K |
4 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
368
|
119K
|
4
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Wonderous
|
368 |
119K |
3 |
17/11/20 |
17/11/20 |
ASX - By Stock
|
368
|
119K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Wonderous
|
13K |
6.3M |
3 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
6.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Wonderous
|
13K |
6.3M |
4 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Wonderous
|
13K |
6.3M |
6 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
6.3M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Wonderous
|
440 |
141K |
3 |
12/11/20 |
12/11/20 |
ASX - By Stock
|
440
|
141K
|
3
|
|
ASX - By Stock
|
RCE |
Re:
Ann: Encouraging Results Against SARS-CoV-2 Virus
|
|
Wonderous
|
81 |
21K |
1 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
81
|
21K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
4 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
221
|
58K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
6 |
30/10/20 |
30/10/20 |
ASX - By Stock
|
221
|
58K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Wonderous
|
53 |
12K |
3 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
53
|
12K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Wonderous
|
53 |
12K |
8 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
53
|
12K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
3 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
221
|
58K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
6 |
28/10/20 |
28/10/20 |
ASX - By Stock
|
221
|
58K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
No Point Thinking Too Much
|
|
Wonderous
|
102 |
36K |
4 |
20/10/20 |
20/10/20 |
ASX - By Stock
|
102
|
36K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
10 |
18/10/20 |
18/10/20 |
ASX - By Stock
|
221
|
58K
|
10
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
8 |
17/10/20 |
17/10/20 |
ASX - By Stock
|
221
|
58K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 HIV-1 Immunomodulatory Paper Published
|
|
Wonderous
|
46 |
18K |
12 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
46
|
18K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 HIV-1 Immunomodulatory Paper Published
|
|
Wonderous
|
46 |
18K |
8 |
16/10/20 |
16/10/20 |
ASX - By Stock
|
46
|
18K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
No Point Thinking Too Much
|
|
Wonderous
|
102 |
36K |
9 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
102
|
36K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 HIV-1 Immunomodulatory Paper Published
|
|
Wonderous
|
46 |
18K |
4 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
46
|
18K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
No Point Thinking Too Much
|
|
Wonderous
|
102 |
36K |
2 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
102
|
36K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
No Point Thinking Too Much
|
|
Wonderous
|
102 |
36K |
4 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
102
|
36K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
No Point Thinking Too Much
|
|
Wonderous
|
102 |
36K |
6 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
102
|
36K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
1 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
221
|
58K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
6 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
221
|
58K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
7 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
221
|
58K
|
7
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Presentation to Investors
|
|
Wonderous
|
48 |
17K |
13 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
48
|
17K
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
2 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
221
|
58K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Wonderous
|
3.2K |
1.0M |
3 |
14/10/20 |
14/10/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Wonderous
|
3.2K |
1.0M |
3 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Wonderous
|
3.2K |
1.0M |
4 |
13/10/20 |
13/10/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
6 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
221
|
58K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
4 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
221
|
58K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Major Article - BIT225, in combination with 3-drug antiretroviral therapy
|
|
Wonderous
|
221 |
58K |
6 |
12/10/20 |
12/10/20 |
ASX - By Stock
|
221
|
58K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Covid-19 - A potent version of airborne HIV?
|
|
Wonderous
|
4 |
2.5K |
8 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
4
|
2.5K
|
8
|
|
ASX - By Stock
|
BIT |
Re:
Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Wonderous
|
8 |
3.4K |
4 |
08/10/20 |
08/10/20 |
ASX - By Stock
|
8
|
3.4K
|
4
|
|
ASX - By Stock
|
BIT Biotech |
Re:
TRUMP COVID19 POSITIVE
|
|
Wonderous
|
23 |
11K |
1 |
03/10/20 |
03/10/20 |
ASX - By Stock
|
23
|
11K
|
1
|
|